NanoViricides sets president Anil Diwan base salary at $400,000 under extension agreement

• NanoViricides extended President Anil R. Diwan’s employment through June 30, 2027, setting an annual base salary of $400,000.
• Diwan received 10,204 shares of Series A Preferred Stock, vesting quarterly from Sept. 30, 2026 through June 30, 2027.
• Terms include a $2 million term life insurance policy, with $1 million assigned to the registrant.
• Severance provides six months’ salary if terminated without cause, with continued benefits during the severance period.
• Chief Financial Officer Meeta Vyas’ contract was extended through June 30, 2027, adding health insurance reimbursement up to $2,500 per month.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-111952), on September 29, 2026, and is solely responsible for the information contained therein.